The largest individual exposures in this window include: Mercks pembrolizumab (Keytruda), with $25 billion in 2023 revenue, faces composition of matter patent expiry in 2028, though secondary patents on specific dosing methods, combination regimens, and PD-1 binding domains extend the formal portfolio timeline
Thats where semaglutide changes the game
Visit : [] [] It is a synthetic peptide that has been widely discussed in relation to pigmentation processes
GLP-1s are no longer just glucose-lowering agents they are reshaping cardiometabolic care
Shah notes that it can also happen with tirzepatides like Zepbound and Mounjaro, among other medications in the class of drugs known as GLP-1 receptor agonists
GLP-1 medications can be a useful part of that journey for some women, and lifestyle changes can help carry those benefits into a healthy pregnancy and beyond